Pets Infectious Disease Screening Market, Global Outlook and Forecast 2025-2032

MARKET INSIGHTS

Global Pets Infectious Disease Screening market size was valued at USD 410 million in 2024 and is projected to grow from USD 428 million in 2025 to USD 544 million by 2032, exhibiting a CAGR of 4.2% during the forecast period.

Pets Infectious Disease Screening involves diagnostic tests designed to detect pathogens in companion animals, including heartworm disease, Lyme disease, Ehrlichiosis, and Anaplasmosis. These screenings utilize blood tests, PCR assays, and rapid diagnostic kits to identify infections early, enabling timely treatment and prevention. The tests are increasingly recommended by veterinary professionals as part of routine pet healthcare protocols.

The market growth is driven by rising pet ownership globally, with 66% of U.S. households owning pets according to APPA. However, regional disparities in veterinary infrastructure and awareness present challenges. Key players like Mars Petcare and CVS Group are expanding diagnostic services, while technological advancements are improving test accuracy and turnaround times. The Asia-Pacific region shows particularly strong growth potential due to increasing pet humanization trends in markets like China and Japan.

MARKET DYNAMICS

MARKET DRIVERS

Rising Pet Ownership and Humanization Trends Fuel Market Expansion

The global pet population continues to surge, with over 850 million pets in households worldwide, creating a substantial customer base for veterinary services. The humanization of pets has transformed animals into family members, with owners increasingly willing to invest in preventive healthcare. Approximately 68% of pet owners now consider routine health screenings essential, up from just 42% five years ago. This behavioral shift is particularly pronounced in urban areas where disposable incomes are higher and pet care awareness has grown substantially.

Technological Advancements in Diagnostic Testing Accelerate Adoption

Recent innovations have revolutionized infectious disease screening with point-of-care testing platforms delivering results in under 15 minutes with 95% accuracy. Multiplex assay technology now enables simultaneous detection of multiple pathogens from a single sample - a capability utilized by over 60% of veterinary clinics for comprehensive screening. The development of portable PCR devices has extended advanced diagnostics beyond specialty clinics to general practices, reducing turnaround times from days to hours while maintaining laboratory-grade precision.

Furthermore, integration with cloud-based veterinary health records allows seamless tracking of pathogen exposure risks and vaccination histories. These digital solutions not only improve diagnostic accuracy but also enable population-level disease monitoring that benefits the entire pet care ecosystem.

MARKET RESTRAINTS

High Costs and Limited Reimbursement Options Constrain Market Penetration

Comprehensive screening panels typically range from $120-$350 depending on the pathogens covered, placing them out of reach for many pet owners. Unlike human healthcare, veterinary services rarely qualify for insurance reimbursement, with only 12% of pet insurance policies covering diagnostic testing. This financial barrier is particularly acute in developing markets where per capita spending on pet healthcare remains below $15 annually compared to over $300 in developed nations.

Clinics also face significant upfront investments in testing equipment, with advanced analyzers costing $25,000-$75,000, creating adoption barriers for smaller practices. These economic factors collectively slow market growth despite the clear medical benefits of routine infectious disease screening.

MARKET CHALLENGES

Regulatory Complexity and Standardization Issues Present Ongoing Hurdles

The veterinary diagnostic sector faces fragmented regulatory environments with requirements varying significantly across regions. While some jurisdictions mandate stringent validation protocols, others lack clear guidelines for test approvals. This inconsistency forces manufacturers to navigate multiple certification processes, increasing time-to-market by 30-45% on average.

Other Challenges

Sample Transport Limitations
Many screening tests require specialized handling of biological samples, yet only 40% of veterinary clinics have access to certified transport networks. This creates logistical challenges for rural practices needing to send samples to reference laboratories.

Client Education Gaps
Despite growing awareness, nearly 60% of pet owners underestimate the risks of asymptomatic infections. Overcoming misconceptions about the value of preventive screening remains an ongoing challenge for veterinary professionals.

MARKET OPPORTUNITIES

Emerging Markets and Telemedicine Integration Offer Growth Potential

Developing economies represent the fastest-growing segment, with the Asia-Pacific veterinary diagnostics market projected to expand at 7.9% CAGR through 2030. Rising middle-class populations and increasing pet adoption rates create substantial untapped potential. The integration of telemedicine platforms with at-home testing kits allows comprehensive screening programs to reach previously underserved regions - a model already adopted by 25% of veterinary service providers in metropolitan areas.

Collaborations between diagnostic manufacturers and veterinary chains are also driving market expansion. Recent partnerships have focused on developing cost-effective screening packages bundled with wellness plans, improving accessibility while ensuring consistent testing volumes for service providers.

Segment Analysis:

By Type

Heartworm Disease Segment Dominates Due to High Prevalence and Annual Screening Recommendations

The market is segmented based on type into:

• Heartworm Disease

• Lyme Disease

• Ehrlichiosis

• Anaplasmosis

• Others

By Application

Pet Dog Segment Leads Market Share Due to Higher Ownership Rates and Veterinary Care Adoption

The market is segmented based on application into:

• Pet Cat

• Pet Dog

• Other Companion Animals

By End User

Veterinary Clinics Maintain Market Dominance Through Comprehensive Diagnostic Services

The market is segmented based on end user into:

• Veterinary Clinics

• Veterinary Hospitals

• Diagnostic Laboratories

• Research Institutions

COMPETITIVE LANDSCAPE

Key Industry Players

Expanding Pet Healthcare Needs Drive Competition Among Veterinary Diagnostics Providers

The global pets infectious disease screening market features a competitive mix of veterinary diagnostic companies, pet healthcare providers, and specialty laboratories. Mars, Inc. leads the market through its Idexx Laboratories subsidiary, which holds an estimated 28% revenue share in 2024 due to its comprehensive diagnostic panels and extensive veterinary clinic network across North America and Europe.

CVS Group and MedVet have emerged as significant regional players, particularly in the European market where preventive pet healthcare adoption is growing at 6.3% annually. These companies are leveraging their established veterinary networks to offer integrated screening services alongside primary care.

Meanwhile, PetVet Care Centers and PetIQ are aggressively expanding their testing capabilities through acquisitions. PetIQ's 2023 acquisition of VetIQ diagnostics strengthened its position in point-of-care testing, while PetVet's partnership with regional laboratories has enhanced its infectious disease screening portfolio.

Chinese contender New Ruipeng Pet Healthcare Group dominates the Asia-Pacific market, capitalizing on China's rapidly growing pet population which reached 120 million in 2023. Their strategy focuses on affordable screening packages for urban pet owners, driving 18% year-over-year growth in diagnostic service revenue.

List of Key Pets Infectious Disease Screening Companies Profiled

• Mars, Inc. (U.S.)

• CVS Group (U.K.)

• MedVet (U.S.)

• PetVet Care Centers (U.S.)

• New Ruipeng Pet Healthcare Group (China)

• PetIQ, Inc. (U.S.)

• Vetco (U.S.)

• Aiken Veterinary Clinic (U.S.)

• Dehart Veterinary Services (U.S.)

PETS INFECTIOUS DISEASE SCREENING MARKET TRENDS

Rising Pet Ownership and Health Awareness Drive Market Growth

The global pets infectious disease screening market is experiencing robust growth, fueled by increasing pet ownership and heightened awareness of preventive healthcare. With over 66% of U.S. households owning pets and total industry sales reaching $136.8 billion, veterinary care expenditure is expanding rapidly. Infectious disease screening, including tests for heartworm, Lyme disease, and other zoonotic infections, has become standard practice in developed markets, growing at a 4.2% CAGR. This trend is further supported by pet humanization, where owners increasingly view companion animals as family members worthy of sophisticated medical attention.

Other Trends

Technological Advancements in Diagnostic Testing

Veterinary diagnostics are undergoing a technological revolution with the introduction of PCR-based testing platforms, multiplex assays, and point-of-care devices that deliver results within minutes. These innovations enable veterinarians to detect multiple pathogens from a single sample with over 95% accuracy, reducing the need for follow-up visits. The shift toward molecular diagnostics is particularly notable for tick-borne disease screening, where traditional serological tests often yield false negatives during early infection stages.

Expansion of Veterinary Healthcare Infrastructure

The market is benefiting from global expansion of veterinary care networks, including corporate-owned chains and emergency specialty hospitals. Major players like Mars Petcare and CVS Group are establishing comprehensive diagnostic centers that standardize infectious disease protocols across their networks. Emerging markets show particular promise, with China's pet healthcare segment growing over 20% annually as urbanization increases disposable income for pet care services. However, regional disparities in veterinary service availability remain a challenge, with rural areas often lacking access to advanced screening technologies.

Regional Analysis: Pets Infectious Disease Screening Market

North America
The North American market dominates the global Pets Infectious Disease Screening industry, driven by high pet ownership rates and advanced veterinary healthcare infrastructure. With 66% of U.S. households owning pets, per the American Pet Products Association (APPA), demand for preventive care like infectious disease testing remains consistently strong. The region emphasizes comprehensive screening protocols, particularly for heartworm and tick-borne diseases such as Lyme and Ehrlichiosis, due to their prevalence in certain geographic areas. Major players like Mars and PetIQ, Inc. have expanded their diagnostic portfolios to meet this demand. However, cost sensitivity among pet owners and inconsistent awareness in rural areas pose challenges to universal adoption.

Europe
Europe’s market is characterized by strict animal health regulations and a growing focus on zoonotic disease prevention. Countries like Germany, where pet ownership exceeds 33 million animals, prioritize screening for diseases transmissible to humans, such as leptospirosis. The EU’s harmonized veterinary policies encourage standardized testing, though adoption varies: Western Europe leads in advanced diagnostics, while Eastern Europe lags due to affordability barriers. CVS Group and Vetco have capitalized on this trend, offering bundled wellness plans that include screenings. The shift toward pet insurance coverage further supports market growth, particularly in the U.K. and Nordic countries.

Asia-Pacific
As the fastest-growing region, Asia-Pacific benefits from rising disposable incomes and urbanization, which fuel pet humanization trends. China’s pet healthcare market, valued at $5.8 billion in 2023, reflects surging demand for preventive care, though infectious disease screening penetration remains low outside urban centers. Japan and South Korea exhibit higher adoption rates, driven by stringent pet import/export testing requirements. Local players like New Ruipeng Pet Healthcare Group dominate through affordable testing solutions, while international brands face pricing pressures. Challenges include fragmented veterinary networks and limited awareness in rural India and Southeast Asia.

South America
The region presents untapped potential, with Brazil and Argentina leading in veterinary infrastructure development. Increasing pet ownership—Brazil has the second-highest dog population globally—creates opportunities for screening services. However, economic volatility restricts access to advanced diagnostics, and price-based competition limits profitability for providers. Government initiatives to control zoonotic outbreaks, such as leishmaniasis, are gradually boosting demand. Local clinics like Vegreville Veterinary Clinic focus on cost-effective rapid tests, while multinationals face adoption hurdles due to low pet insurance coverage.

Middle East & Africa
This emerging market is constrained by limited veterinary access but shows promise in affluent Gulf states like the UAE and Saudi Arabia, where expatriate demand drives premium pet care. Screening is often tied to pet travel regulations, creating niche opportunities for clinics offering standardized testing. Elsewhere, poverty and underdeveloped animal health systems suppress growth, though NGOs and government programs aim to improve disease surveillance. The lack of local manufacturing necessitates imports, increasing costs. Long-term potential lies in urbanization and rising pet expenditure among middle-class households.

Report Scope

This market research report offers a holistic overview of global and regional markets for the forecast period 2025–2032. It presents accurate and actionable insights based on a blend of primary and secondary research.

Key Coverage Areas:

• ✅ Market Overview

  • Global and regional market size (historical & forecast)

  • Growth trends and value/volume projections

• ✅ Segmentation Analysis

  • By product type or category

  • By application or usage area

  • By end-user industry

  • By distribution channel (if applicable)

• ✅ Regional Insights

  • North America, Europe, Asia-Pacific, Latin America, Middle East & Africa

  • Country-level data for key markets

• ✅ Competitive Landscape

  • Company profiles and market share analysis

  • Key strategies: M&A, partnerships, expansions

  • Product portfolio and pricing strategies

• ✅ Technology & Innovation

  • Emerging technologies and R&D trends

  • Automation, digitalization, sustainability initiatives

  • Impact of AI, IoT, or other disruptors (where applicable)

• ✅ Market Dynamics

  • Key drivers supporting market growth

  • Restraints and potential risk factors

  • Supply chain trends and challenges

• ✅ Opportunities & Recommendations

  • High-growth segments

  • Investment hotspots

  • Strategic suggestions for stakeholders

• ✅ Stakeholder Insights

  • Target audience includes manufacturers, suppliers, distributors, investors, regulators, and policymakers

FREQUENTLY ASKED QUESTIONS:

What is the current market size of Global Pets Infectious Disease Screening Market?

-> The Global Pets Infectious Disease Screening market was valued at USD 410 million in 2024 and is expected to reach USD 544 million by 2032, growing at a CAGR of 4.2% during the forecast period.

Which key companies operate in Global Pets Infectious Disease Screening Market?

-> Key players include Mars, CVS Group, MedVet, PetVet Care Centers, New Ruipeng Pet Healthcare Group, PetIQ, Inc., Vetco, Aiken Veterinary Clinic, Dehart Veterinary Services, Beloved Pet Hospital, and Vegreville Veterinary Clinic.

What are the key growth drivers?

-> Key growth drivers include rising pet ownership (66% of U.S. households own pets), increasing awareness of zoonotic diseases, and growing expenditure on pet healthcare (global pet industry valued at USD 261 billion in 2022).

Which region dominates the market?

-> North America currently leads the market with USD 136.8 billion in pet industry sales (2021), while Asia-Pacific shows the fastest growth due to increasing pet humanization trends.

What are the emerging trends?

-> Emerging trends include AI-powered diagnostic tools, at-home testing kits, and integration of telemedicine for veterinary services. The market is also seeing increased focus on preventive healthcare with 33% of Chinese pet spending going to medicine/healthcare.